Metal–Organic Framework-Based Nano-Activators Facilitating Microwave Combined Therapy via a Divide-and-Conquer Tactic for Triple-Negative Breast Cancer
- 14 December 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 17 (24) , 25575-25590
Abstract
Aiming at the clinical problems of high recurrence and metastasis rate of triple-negative breast cancer, a divide-and-conquer tactic is developed. The designed nanoactivators enhance microwave thermo-dynamic-chemotherapy to efficiently kill primary tumors, simultaneously ameliorate the immunosuppressive microenvironment, activate the tumor infiltration of T lymphocytes, and enhance the accumulation and penetration of PD-1/PD-L1 immune agents, ultimately boosting the efficacy of immune checkpoint blocking therapy to achieve efficient inhibition of distal tumors and metastases. Metal-organic framework (MOF)-based MPPT nano-activator is synthesized by packaging chemotherapeutic drug Pyrotinib and immunosuppressant PD-1/PD-L1 inhibitor 2 into MnCa-MOF and then coupling target molecule triphenylphosphine, which significantly improved the accumulation and penetration of Pyrotinib and immunosuppressant in tumors. In addition to the combined treatment of microwave thermo-dynamic-chemotherapy under microwave irradiation, Mn2+ in the nano-activator comprehensively promotes the cGAS-STING pathway to activate innate immunity, microwave therapy, and hypoxia relief are combined to ameliorate the tumor immunosuppressive microenvironment. The released Pyrotinib down-regulates epidermal growth factor receptor and its downstream pathways PI3K/AKT/mTOR and MAPK/ERK signaling pathways to maximize the therapeutic effect of immune checkpoint blocking, which helps to enhance the antitumor efficacy and promote long-term memory immunity. This nano-activator offers a generally promising paradigm for existing clinical triple-negative breast cancer treatment through a divide-and-conquer strategy.Keywords
Funding Information
- Natural Science Foundation of Beijing Municipality (4222019, JQ23035)
- Natural Science Foundation of Heilongjiang Province (YQ2023H023)
- National Natural Science Foundation of China (82172041, 81801808, 62001456, U20A20335)
This publication has 56 references indexed in Scilit:
- Continuous “Snowing” Thermotherapeutic GrapheneAdvanced Materials, 2020
- A Combination of Radiotherapy, Hyperthermia, and Immunotherapy Inhibits Pancreatic Tumor Growth and Prolongs the Survival of MiceCancers, 2020
- Neoadjuvant checkpoint blockade for cancer immunotherapyScience, 2020
- The Cytosolic DNA-Sensing cGAS–STING Pathway in CancerCancer Discovery, 2020
- Dual-Functional Supernanoparticles with Microwave Dynamic Therapy and Microwave Thermal TherapyNano Letters, 2019
- A Biocompatible Heterogeneous MOF–Cu Catalyst for In Vivo Drug Synthesis in Targeted Subcellular OrganellesAngewandte Chemie International Edition, 2019
- Targeting DDR2 enhances tumor response to anti–PD-1 immunotherapyScience Advances, 2019
- Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapyNature Nanotechnology, 2019
- Cancer immunotherapy using checkpoint blockadeScience, 2018
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous diseaseNature Reviews Clinical Oncology, 2016